Vousden Karen H
SEC insider (Form 3/4/5 filer). CIK 0001723884. Director at Faeth Therapeutics, Inc. (FTH) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Sep 11, 2026. Located in AUSTIN, TX.
Companies Vousden Karen H has filed insider reports for
- Faeth Therapeutics, Inc. (FTH): Director
- BRISTOL MYERS SQUIBB CO (BMY): Director
Vousden Karen H
CIK: 0001723884
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Sep 11, 2026FTH
Faeth Therapeutics, Inc.
AwardDirectStock Option (right to buy)
25K shares- - Feb 1, 2026BMY
BRISTOL MYERS SQUIBB CO
AwardDirectDeferred Share Units
4K shares at avg. $55.05- - Feb 1, 2025BMY
BRISTOL MYERS SQUIBB CO
AwardDirectDeferred Share Units
3.6K shares at avg. $58.95-
1-3 of 3 transactions